Review
A progress report on reimbursement of biotherapy: prospects for the 1990s
- PMID: 2687813
Item in Clipboard
Review
A progress report on reimbursement of biotherapy: prospects for the 1990s
Oncol Nurs Forum.
1989 Nov-Dec.
Abstract
Reimbursement of cancer care associated with clinical trials continues to be a growing national concern. Cancer organizations have taken many actions to draw attention to an economic force with the potential to seriously hamper oncology research. Strategies are described that could prove useful to cancer care professionals as they attempt to influence reimbursement policies.
Similar articles
-
Reimbursement of biotherapy: present status, future directions--perspectives of the hospital-based oncology nurse.Semin Oncol Nurs. 1992 Nov;8(4 Suppl 1):3-7. doi: 10.1016/0749-2081(92)90047-7. Semin Oncol Nurs. 1992. PMID: 1462056
-
Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.J Natl Cancer Inst Monogr. 1998;(24):1-28. J Natl Cancer Inst Monogr. 1998. PMID: 9704318 Review. No abstract available.
-
Patient education resources related to biotherapy and the immune system.Oncol Nurs Forum. 1994 Aug;21(7):1223-8. Oncol Nurs Forum. 1994. PMID: 7971432
-
Barriers to clinical trial enrollment: are state mandates the solution?J Natl Cancer Inst. 2004 Jul 21;96(14):1048-9. doi: 10.1093/jnci/djh225. J Natl Cancer Inst. 2004. PMID: 15265958 No abstract available.
-
An odyssey into biologic therapy.Oncol Nurs Forum. 1993 Jul;20(6):879-87. Oncol Nurs Forum. 1993. PMID: 8367342 Review. No abstract available.
Cited by
-
Optimising the economic efficiency of drug studies.Pharmacoeconomics. 1992 Nov;2(5):371-87. doi: 10.2165/00019053-199202050-00005. Pharmacoeconomics. 1992. PMID: 10147050 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical